# Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients

> **NCT05371184** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** L-Glutamine, Oral Powder for Reconstitution
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT05371184
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-04
- **Primary completion:** 2023-01-03
- **Final completion:** 2024-01-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05371184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05371184, "Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05371184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*